Strontium ranelate

Key facts

Invented name
Osseor
Active substance
strontium ranelate
Therapeutic area
Immunology-Rheumatology-Transplantation
Decision number
P/24/2010
PIP number
Strontium ranelate
Pharmaceutical form(s)
Granules for oral suspension
Condition(s) / indication(s)
Osteoporosis
Route(s) of administration
Oral use
Contact for public enquiries
Les Laboratoires Servier
E-mail: mail.pip.enquiries@fr.netgrs.com
Country: France
Phone: +33 155726000
Fax: +33 155725044
Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating